| Mucin-Producing Carcinoma studied in …STUDIED_INderived23 of 23show fewer |
|---|
| → studied in | NCT02978625Phase 2 · active not recruiting Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers · condition mapped ONTOLOGY_EXACT · 23 trials mapped (2 active) | — | — | Endocrine Mucin-Producing Sweat Gland Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01473784NA · recruiting Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck · condition mapped CURATED_BROADER · 23 trials mapped (2 active) | — | — | Oral Cavity Mucoepidermoid Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04249947Phase 1 · terminated P-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Advanced Salivary Gland Cancers (SGC) · condition mapped ONTOLOGY_EXACT · 23 trials mapped (2 active) | — | — | Mucoepidermoid Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01586767NA · unknown Intensity-Modulated or Proton Radiation Therapy for Sinonasal Malignancy · condition mapped ONTOLOGY_EXACT · 23 trials mapped (2 active) | — | — | Mucoepidermoid Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03602079Phase 1/Phase 2 · completed Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene · condition mapped ONTOLOGY_EXACT · 23 trials mapped (2 active) | — | — | Mucoepidermoid Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00470496Phase 1 · completed Photodynamic Therapy Using HPPH in Treating Patients Undergoing Surgery for Primary or Recurrent Head and Neck Cancer · condition mapped CURATED_BROADER · 23 trials mapped (2 active) | — | — | Oral Cavity Mucoepidermoid Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01806675Phase 1/Phase 2 · completed 18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy · condition mapped CURATED_BROADER · 23 trials mapped (2 active) | — | — | Oral Cavity Mucoepidermoid Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02123511Phase 2 · completed Acetylcysteine Rinse in Reducing Saliva Thickness and Mucositis in Patients With Head and Neck Cancer Undergoing Radiation Therapy · condition mapped CURATED_BROADER · 23 trials mapped (2 active) | — | — | Oral Cavity Mucoepidermoid Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01164566NA · terminated Esophagoscopy in Evaluating Treatment in Patients With Stage I-IV Head and Neck Cancer Who Are Undergoing Radiation Therapy and/or Chemotherapy · condition mapped CURATED_BROADER · 23 trials mapped (2 active) | — | — | Oral Cavity Mucoepidermoid Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00095563Phase 2 · completed Lapatinib in Treating Patients With Recurrent and/or Metastatic Adenoid Cystic Cancer or Other Salivary Gland Cancers · condition mapped ALIAS · 23 trials mapped (2 active) | — | — | Salivary Gland High Grade Mucoepidermoid Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00397384Phase 1 · completed Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer · condition mapped CURATED_BROADER · 23 trials mapped (2 active) | — | — | Oral Cavity Mucoepidermoid Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01254734NA · terminated Transoral Robotic Surgery in Treating Patients With Benign or Stage I-IV Head and Neck Cancer · condition mapped CURATED_BROADER · 23 trials mapped (2 active) | — | — | Oral Cavity Mucoepidermoid Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00101348Phase 1/Phase 2 · completed Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer · condition mapped CURATED_BROADER · 23 trials mapped (2 active) | — | — | Oral Cavity Mucoepidermoid Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00492089Phase 2 · completed Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck Cancer · condition mapped CURATED_BROADER · 23 trials mapped (2 active) | — | — | Oral Cavity Mucoepidermoid Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00031681Phase 1 · completed 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) · condition mapped CURATED_BROADER · 23 trials mapped (2 active) | — | — | Oral Cavity Mucoepidermoid Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01155609NA · completed L-lysine in Treating Oral Mucositis in Patients Undergoing Radiation Therapy With or Without Chemotherapy For Head and Neck Cancer · condition mapped CURATED_BROADER · 23 trials mapped (2 active) | — | — | Oral Cavity Mucoepidermoid Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00089362Phase 1 · completed Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors · condition mapped CURATED_BROADER · 23 trials mapped (2 active) | — | — | Oral Cavity Mucoepidermoid Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00004074Phase 1 · completed Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu · condition mapped CURATED_BROADER · 23 trials mapped (2 active) | — | — | Oral Cavity Mucoepidermoid Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00126607Phase 2 · terminated Trastuzumab in Treating Patients With Metastatic or Recurrent Salivary Gland Cancer · condition mapped ALIAS · 23 trials mapped (2 active) | — | — | Salivary Gland High Grade Mucoepidermoid Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00023959Phase 1 · completed Bevacizumab, Fluorouracil, and Hydroxyurea Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer · condition mapped CURATED_BROADER · 23 trials mapped (2 active) | — | — | Oral Cavity Mucoepidermoid Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00030498Phase 1 · completed Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction · condition mapped CURATED_BROADER · 23 trials mapped (2 active) | — | — | Oral Cavity Mucoepidermoid Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00068497NA · completed Gefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung Cancer · condition mapped CURATED_BROADER · 23 trials mapped (2 active) | — | — | Oral Cavity Mucoepidermoid Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01637194Phase 1 · completed Cetuximab and Everolimus in Treating Patients With Metastatic or Recurrent Colon Cancer or Head and Neck Cancer · condition mapped CURATED_BROADER · 23 trials mapped (2 active) | — | — | Oral Cavity Mucoepidermoid Carcinoma | 1 | Observed | clinicaltrials | graph → |